Matches in SemOpenAlex for { <https://semopenalex.org/work/W2492640320> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2492640320 endingPage "124" @default.
- W2492640320 startingPage "115" @default.
- W2492640320 abstract "Objective To review the use of leukotriene modifiers in exercise-induced bronchoconstriction (EIB). Data Source A MEDLINE search (1966–March 2001) identified pertinent English-language publications on EIB in humans. Study Selection Selection of prospective clinical studies was limited to those that focused on prevention of EIB with leukotriene modifiers, including both leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Data Synthesis Leukotriene modifiers have been shown to attenuate EIB in patients with mild to intermittent, stable asthma from exacerbations after exercise, especially those with a predicted forced expiratory volume in 1 second (FEV 1 ) >80% and who did not require corticosteroids. Extrapolation to patients with more severe forms of asthma cannot be made because of the lack of currently available data in these types of patients. Children may benefit from the oral dosage forms of leukotriene modifiers if they have difficulty using a metered-dose inhaler. The current literature supports a lack of a tolerance effect with leukotriene modifiers, as opposed to tachyphylaxis seen with beta 2 -adrenergic drugs after repeated dosing. As many as 25% of EIB patients will not respond to therapy with leukotriene modifiers. Montelukast has the greatest volume of data and the most positive benefits of the available leukotriene modifiers. Conclusions Evidence supports the use of leukotriene modifiers for protection of EIB in patients with stable, mild to intermittent asthma with a predicted FEV 1 ≥80% if beta-agonists are intolerable or ineffective. Potential benefits include the lack of a tolerance effect, the long duration of action exhibited by some leukotriene modifiers, and the availability of a tablet form. Beta 2 -adrenergic drugs should remain the first-line therapy for EIB; however, leukotriene modifiers may provide a valuable alternative in those few who cannot use short-acting beta-agonists. Long-term safety studies of leukotriene modifiers in children and the elderly with EIB are necessary before widespread use can be advocated in the pediatric and geriatric populations." @default.
- W2492640320 created "2016-08-23" @default.
- W2492640320 creator A5016974423 @default.
- W2492640320 creator A5061737570 @default.
- W2492640320 date "2002-05-01" @default.
- W2492640320 modified "2023-09-25" @default.
- W2492640320 title "The Role of Leukotriene Modifiers in the Management of Exercise-Induced Bronchoconstriction" @default.
- W2492640320 cites W1966364214 @default.
- W2492640320 cites W1981916494 @default.
- W2492640320 cites W1985400158 @default.
- W2492640320 cites W1992272014 @default.
- W2492640320 cites W1993793555 @default.
- W2492640320 cites W2014473048 @default.
- W2492640320 cites W2034135161 @default.
- W2492640320 cites W2037971296 @default.
- W2492640320 cites W2043101861 @default.
- W2492640320 cites W2062381360 @default.
- W2492640320 cites W2070289515 @default.
- W2492640320 cites W2070348992 @default.
- W2492640320 cites W2072613930 @default.
- W2492640320 cites W2073044541 @default.
- W2492640320 cites W2078534806 @default.
- W2492640320 cites W2081751821 @default.
- W2492640320 cites W2093063293 @default.
- W2492640320 cites W2099602430 @default.
- W2492640320 cites W2099997075 @default.
- W2492640320 cites W2129043402 @default.
- W2492640320 cites W2134763964 @default.
- W2492640320 cites W2152481094 @default.
- W2492640320 cites W2166915910 @default.
- W2492640320 cites W2170723975 @default.
- W2492640320 cites W2337619606 @default.
- W2492640320 cites W2341700252 @default.
- W2492640320 doi "https://doi.org/10.1177/875512250201800301" @default.
- W2492640320 hasPublicationYear "2002" @default.
- W2492640320 type Work @default.
- W2492640320 sameAs 2492640320 @default.
- W2492640320 citedByCount "0" @default.
- W2492640320 crossrefType "journal-article" @default.
- W2492640320 hasAuthorship W2492640320A5016974423 @default.
- W2492640320 hasAuthorship W2492640320A5061737570 @default.
- W2492640320 hasConcept C168481208 @default.
- W2492640320 hasConcept C203014093 @default.
- W2492640320 hasConcept C2776042228 @default.
- W2492640320 hasConcept C2776322731 @default.
- W2492640320 hasConcept C2776452501 @default.
- W2492640320 hasConcept C2780212800 @default.
- W2492640320 hasConcept C2780769369 @default.
- W2492640320 hasConcept C42219234 @default.
- W2492640320 hasConcept C71924100 @default.
- W2492640320 hasConcept C98274493 @default.
- W2492640320 hasConceptScore W2492640320C168481208 @default.
- W2492640320 hasConceptScore W2492640320C203014093 @default.
- W2492640320 hasConceptScore W2492640320C2776042228 @default.
- W2492640320 hasConceptScore W2492640320C2776322731 @default.
- W2492640320 hasConceptScore W2492640320C2776452501 @default.
- W2492640320 hasConceptScore W2492640320C2780212800 @default.
- W2492640320 hasConceptScore W2492640320C2780769369 @default.
- W2492640320 hasConceptScore W2492640320C42219234 @default.
- W2492640320 hasConceptScore W2492640320C71924100 @default.
- W2492640320 hasConceptScore W2492640320C98274493 @default.
- W2492640320 hasIssue "3" @default.
- W2492640320 hasLocation W24926403201 @default.
- W2492640320 hasOpenAccess W2492640320 @default.
- W2492640320 hasPrimaryLocation W24926403201 @default.
- W2492640320 hasRelatedWork W1606916251 @default.
- W2492640320 hasRelatedWork W2037971296 @default.
- W2492640320 hasRelatedWork W2043240135 @default.
- W2492640320 hasRelatedWork W2094029243 @default.
- W2492640320 hasRelatedWork W2094363842 @default.
- W2492640320 hasRelatedWork W2332656532 @default.
- W2492640320 hasRelatedWork W3181073615 @default.
- W2492640320 hasRelatedWork W4299148371 @default.
- W2492640320 hasRelatedWork W2089544806 @default.
- W2492640320 hasRelatedWork W2181325742 @default.
- W2492640320 hasVolume "18" @default.
- W2492640320 isParatext "false" @default.
- W2492640320 isRetracted "false" @default.
- W2492640320 magId "2492640320" @default.
- W2492640320 workType "article" @default.